ClinicalTrialsFinder

Early Small (cT1N0) Triple Negative Breast Cancer Clinical Trials in Lyon

1 recruitingLyon, France

Showing 1–1 of 1 trials

Recruiting
Phase 2

Short-term Pre-OPerative Durvalumab (MEDI 4736) in Early Small Triple Negative Breast Cancer Patients (POP-Durva)

Early Small (cT1N0) Triple Negative Breast Cancer
Gustave Roussy, Cancer Campus, Grand Paris200 enrolled3 locationsNCT05215106